perfosfamide has been researched along with Recrudescence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggs, D; Buzby, G; Edelstein, M; Magee, D; Mangan, P; Powlis, W; Sachs, B; Silberstein, L; Stadtmauer, E | 1 |
| Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
| Ambinder, RF; Braine, H; Brodsky, RA; Flinn, IW; Fuchs, EJ; Fuller, D; Gore, SD; Jones, RJ; Lee, SM; Miller, CB; Noga, SJ; O'Donnell, PV; Piantadosi, S; Smith, BD; Vala, MS; Vogelsang, GB | 1 |
| Colvin, M; Mangan, KF; Przepiorka, D; Rosenfeld, C; Shadduck, RK | 1 |
| Gorin, NC | 1 |
1 trial(s) available for perfosfamide and Recrudescence
| Article | Year |
|---|---|
4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Recurrence; Transplantation, Autologous | 1994 |
4 other study(ies) available for perfosfamide and Recrudescence
| Article | Year |
|---|---|
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Neutrophils; Prognosis; Recurrence; Remission Induction; Transplantation, Autologous | 2002 |
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse.
Topics: Actuarial Analysis; Adult; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Child; Cyclophosphamide; Female; Graft Rejection; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Postoperative Complications; Recurrence; Remission Induction; Transplantation, Autologous | 1989 |
Autologous bone marrow transplantation in acute leukemia.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow Transplantation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Magnetics; Neprilysin; Rabbits; Recurrence; Ricin; Transplantation, Autologous; Whole-Body Irradiation | 1986 |